Foto del docente

Marco Novelli

Associate Professor

Department of Statistical Sciences "Paolo Fortunati"

Academic discipline: STAT-01/A Statistics

Publications

Luati, Alessandra; Novelli, Marco, Explicit-duration Hidden Markov Models for quantum state estimation, «COMPUTATIONAL STATISTICS & DATA ANALYSIS», 2021, 158, Article number: 107183 , pp. 1 - 13 [Scientific article]Open Access

Novelli, Marco; Cazzola, Alberto; Angeli, Aurora; Pasquini, Lucia, Fertility Intentions in Times of Rising Economic Uncertainty: Evidence from Italy from a Gender Perspective, «SOCIAL INDICATORS RESEARCH», 2021, 154, pp. 257 - 284 [Scientific article]Open Access

Marco Novelli, Information borrowing in phase II basket trials: a comparison of different designs, in: Book of Short Papers SIS 2021, 2021, pp. 572 - 577 (atti di: SIS 2021, Pisa, 21-25/6/2021) [Contribution to conference proceedings]

Rizzo, A.; Frega, G.; Palloni, A.; Piemontese, A.; Di Federico, A.; Ricci, A.; Carloni, R.; Fabbri, F.; Novelli, M.; Tavolari, S.; Di Marco, M.; Ravaioli, M.; Brandi, G., Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience, «ANNALS OF ONCOLOGY», 2021, 32, Article number: P-69 , pp. S120 - S120 [Scientific article]

BALDI ANTOGNINI, Alessandro; Frieri, Rosamarie; Novelli, Marco; Zagoraiou, Maroussa, Multi-objective optimal allocations for experimental studies with binary outcome, in: Book of Short Papers SIS 2021 pt. 1, Pearson, 2021, pp. 621 - 626 (atti di: SIS 2021, Pisa (online), 21-25 Giugno 2021) [Contribution to conference proceedings]

Baldi Antognini, Alessandro; Frieri, Rosamarie; Novelli, Marco; Zagoraiou, Maroussa, Optimal designs for testing the efficacy of heterogeneous experimental groups, «ELECTRONIC JOURNAL OF STATISTICS», 2021, 15, pp. 3217 - 3248 [Scientific article]Open Access

Novelli, Marco; Baldi Antognini, Alessandro; Boffetta, Paolo; Ioannidis, John PA; Spatari, Giovanna; Violante, Francesco S, Reporting only relative effect measures was potentially misleading: some good practices for improving the soundness of epidemiological results, «JOURNAL OF CLINICAL EPIDEMIOLOGY», 2021, 137, pp. 195 - 199 [Scientific article]Open Access

Nannini, M.; Rizzo, A.; Nigro, M. C.; Vincenzi, B.; Mazzocca, A.; Grignani, G.; Merlini, A.; D'Ambrosio, L.; Tolomeo, F.; Badalamenti, G.; Incorvaia, L.; Bonasera, A.; Fumagalli, E.; Miliziano, D.; Ligorio, F.; Brunello, A.; Chiusole, B.; Gasperoni, S.; Novelli, M.; Pantaleo, M. A., Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study, «ESMO OPEN», 2021, 6, Article number: 100222 , pp. 100222 - 100228 [Scientific article]Open Access

Nannini, Margherita; Rizzo, Alessandro; Nigro, Maria Concetta; Vincenzi, Bruno; Mazzocca, Alessandro; Grignani, Giovanni; Tolomeo, Francesco; D'Ambrosio, Lorenzo; Badalamenti, Giuseppe; Bonasera, Annalisa; Fumagalli, Elena; Miliziano, Daniela; Brunello, Antonella; Chiusole, Benedetta; Gasperoni, Silvia; Novelli, Marco; Pantaleo, Maria A., Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study, «JOURNAL OF CLINICAL ONCOLOGY», 2021, 39, Article number: e23521 , pp. 1 - 1 [Scientific article]

Martin Forster; Marco Novelli, Adaptive clinical trials: Bayesian decision-theoretic and frequentist approaches for cost-effectiveness analysis, in: A. Pollice, N. Salvati, F. Schirippa Spagnolo, Book of short Papers SIS 2020, 2020, pp. 739 - 744 (atti di: SIS 2020, Pisa, 6/2020) [Contribution to conference proceedings]

Baldi Antognini, Alessandro; Novelli, Marco; Zagoraiou, Maroussa; Vagheggini, Alessandro, Compound optimal allocations for survival clinical trials, «BIOMETRICAL JOURNAL», 2020, 62, pp. 1730 - 1746 [Scientific article]Open Access

Alessandro Rizzo; Margherita Nannini; Marco Novelli; Angela Dalia Ricci; Valerio Di Scioscio; Maria Abbondanza Pantaleo, Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2020, 12, pp. 1 - 10 [Scientific article]Open Access

Frieri, Rosamarie; Novelli, Marco, Optimal designs for multi-arm exponential trials, in: A. Pollice, N. Salvati, F. Schirippa Spagnolo, Book of short Papers SIS 2020, 2020, pp. 60 - 65 (atti di: SIS 2020, Pisa, 6/2020) [Contribution to conference proceedings]Open Access

ANGELA DALIA RICCI, ALESSANDRO RIZZO, MARCO NOVELLI, SIMONA TAVOLARI, ANDREA PALLONI, NASTASSJA TOBER, FRANCESCA ABBATI, VERONICA MOLLICA, STEFANIA DE LORENZO, DANIELA TURCHETTI, MARIACRISTINA DI MARCO, GIOVANNI BRANDI, Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis, «ANTICANCER RESEARCH», 2020, 40, pp. 597 - 608 [Scientific article]

Luati, Alessandra; Novelli, Marco, The Hammersley–Chapman–Robbins inequality for repeatedly monitored quantum system, «STATISTICS & PROBABILITY LETTERS», 2020, 165, Article number: 108852 , pp. 1 - 6 [Scientific article]Open Access

Latest news

At the moment no news are available.